CMPF

CAS No. 86879-39-2

CMPF( —— )

Catalog No. M36257 CAS No. 86879-39-2

CMPF is a microtubule protein inhibitor that can be used to study tumors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 176 In Stock
10MG 264 In Stock
25MG 449 In Stock
50MG 631 In Stock
100MG 882 In Stock
200MG 1181 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CMPF
  • Note
    Research use only, not for human use.
  • Brief Description
    CMPF is a microtubule protein inhibitor that can be used to study tumors.
  • Description
    CMPF can be found in trace constituent of urine and blood. CMPF is a biomarker of type 2 diabetes. CMPF can act on the β cell and induces impaired mitochondrial function. CMPF decreases glucose-induced ATP accumulation, and induces oxidative stress. CMPF reverses hepatic lipid accumulation and improves insulin sensitivity in obese mice.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Microtubule Associated
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    86879-39-2
  • Formula Weight
    240.25
  • Molecular Formula
    C12H16O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (1040.58 mM; Ultrasonic )
  • SMILES
    C(CC(O)=O)C1=C(C(O)=O)C(C)=C(CCC)O1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Prentice KJ, et al. The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction. Cell Metab. 2014 Apr 1;19(4):653-66.?
molnova catalog
related products
  • Guanosine 5'-monopho...

    Guanosine monophosphate also known as guanylic acid or 5'-GMP belongs to the class of organic compounds known as purine ribonucleoside monophosphates. In particular L-Glutamic acid and guanosine monophosphate can be biosynthesized from xanthylic acid and L-glutamine; which is catalyzed by the enzyme GMP synthase.

  • FR054

    FR054 is an inhibitor of the Hexosamine Biosynthetic Pathway (HBP) enzyme PGM3, with a remarkable anti-breast cancer effect. FR054 induces in different breast cancer cells a dramatic decrease in cell proliferation and survival.

  • [D-Phe6,Leu-NHEt13,d...

    (D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14) is a bombesin (BBN) antagonist and can be used for the research of cancer.